Bioteque (4107.TWO) Stock Price

Bioteque Price

CLOSED
109.50
​
Market closed

Over the last 19 years Bioteque grew revenue by 8.0% annually, reaching 2.14 B TWD. Earnings per share have grown at 13.1% per year over the last 19 years. For Bioteque, the net margin of 25.2% is up versus 23.6% a few years ago. At today's price the dividend yield works out to roughly 4.57%. The payout ratio is around 64% of earnings. The dividend has grown at 3.6% per year over the past 3 years. The consensus 12-month price target for Bioteque is 140.76 TWD, about 28.5% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Bioteque stock price

Access this data via the Eulerpool API

Bioteque business model & stock analysis

Bioteque Corp. is engaged in manufacturing and trading of medical supplies and equipment such as medical plastic tube, medical extended tubes and test apparatus. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-01-02. The firm is also engaged in the importing and exporting of medical equipment. The Company’s primary products include thermoplastic urethane (TPU) tubes, angiography catheters, blood loop tubes, puncture needles, medical use soft bags, transfusion sets, surgery drainage tubes, urethral catheters, precise measuring cylinders, as well as other medical supplies and components. The firm mainly distributes its product within domestic market and to overseas markets, including the rest of Asia, the Americas, Europe and Africa.

Frequently asked questions about Bioteque

Analysts currently set an average price target of 140.76 TWD for the Bioteque stock (median: 140.76 TWD), implying +28.5 % versus the latest price. The consensus is based on 9 analyst ratings.

7 analysts currently rate the Bioteque stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Bioteque to generate revenue of 2.33 B TWD and earnings per share of 8.71 TWD.

Converted at the current exchange rate, the Bioteque share trades at 3.07 EUR (109.50 TWD).

The expected revenue of Bioteque is 2.33 B TWD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bioteque is 603.60 M TWD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bioteque is currently 12.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bioteque stock.

The price-to-sales ratio (P/S) of Bioteque is currently 3.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bioteque stock.

The Eulerpool Quality Score for Bioteque is 5/10.

The ISIN of Bioteque is TW0004107008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bioteque is 4107.TWO. The ticker symbol is used to trade Bioteque shares on the stock exchange.

Fair ValueTerminal
95.27 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jan 2, 2002
ISIN
TW0004107008
Cusip
Y08968102
Market capitalization
7.59 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
12.57
P/Ee 2027
11.81
P/S
P/Se
3.26
EV/EBIT
9.82
P/B Ratio
2.10
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
14.34 %
Dividend
Dividend yield
4.57 %
Est. Dividend Yield
5.02 %
Payout Ratio
64.26 %
Dividend growth Ø5Y
4.10 %
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
4 years
Dividend increased since
1 year
Dividend withholding tax
21.00 %
Last updated Oct 9, 2026, 12:23 AM

Bioteque Peer Group

Bioteque Ticker

TWO · 4107.TWO

Bioteque FIGI

4107:TT (Taipei Stock Exchange) · BBG000DRBYX2

All fundamentals and in-depth analysis of Bioteque

Our stock analysis for Bioteque stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioteque. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.